Abstract
Introduction and hypothesis
Stress urinary incontinence (SUI) is common, impacts women’s quality of life, and generates high costs. Physiotherapy is the first-line therapy, and if it fails, suburethral slings are the gold standard in SUI surgery. Bulking agents injected periurethrally might be a beneficial alternative, but there is a paucity of data on bulking therapy. The aim of this study was to prospectively analyze the efficacy and safety of bulking agents in the setting of a tertiary referral center.
Methods
In the last 13 years, 514 elderly women with SUI were treated by injection therapy with either collagen (Contigen®), hyaluronic acid (Zuidex®), ethylene vinyl alcohol (Tegress®), or polyacrylamide hydrogel (Bulkamid®). Subjective and objective outcome was recorded at the 12-month postoperative appointment using the King’s Health Questionnaire, visual analogue scale (VAS) describing their incontinence severity, standardized pad test, and urethral pressure profile.
Results
Demographic data were equally distributed in all four groups of agents used. Sixty-one patients were lost to follow-up (10.6 %). Statistically significant changes were found for maximum urethral closure pressure (MUCP), pad weight, and VAS before and after bulking for the four agents used. Pad test was negative in 73.2 % of patients after bulking therapy. Subjective assessment showed improvements in general health and role limitations. The overall complication rate was low for all agents.
Conclusions
This study shows improvement in incontinence after bulking therapy according to subjective and objective outcomes in an elderly population. In contrast to earlier reports, side effects due to injections were few and mild. We can advocate bulking therapy for treating SUI, as it is simple, safe, and shows both objective and subjective improvement and relief.
Similar content being viewed by others
References
Blaivas JG, Appell RA, Fantl JA, Leach G, McGuire EJ, Resnick NM et al (1997) Definition and classification of urinary incontinence: recommendations of the urodynamic society. Neurourol Urodyn 16:149–151
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the international continence society. Urology 61:37–49
Mohr S, Kuhn P, Mueller MD, Kuhn A (2011) Painful love-"hispareunia" after sling erosion of the female partner. J Sex Med 8:1740–1746
Kerr LA (2005) Bulking agents in the treatment of stress urinary incontinence: history, outcomes, patient populations, and reimbursement profile. Rev Urol 7(Suppl 1):S3–S11
Papanicolaou S, Pons ME, Hampel C, Monz B, Quail D, Schulenburg MG et al (2005) Medical resource utilisation and cost of care for women seeking treatment for urinary incontinence in an outpatient setting. Examples from three countries participating in the PURE study. Maturitas 52(Suppl 2):S35–S47
Shamliyan TA, Kane RL, Wyman J, Wilt TJ (2008) Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med 148:459–473
Serati M, Salvatore S, Uccella S, Artibani W, Novara G, Cardozo L et al (2009) Surgical treatment for female stress urinary incontinence: what is the gold-standard procedure? Int Urogynecol J Pelvic Floor Dysfunct 20:619–621
Davila GW (2011) Nonsurgical outpatient therapies for the management of female stress urinary incontinence: long-term effectiveness and durability. Adv Urol 2011:176498
Sassani P, Aboseif SR (2009) Stress urinary incontinence in women. Curr Urol Rep 10:333–337
Keegan PE, Atiemo K, Cody J, McClinton S, Pickard R (2007) Periurethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev CD003881
Chapple CR, Wein AJ, Brubaker L, Dmochowski R, Pons ME, Haab F et al (2005) Stress incontinence injection therapy: what is best for our patients? Eur Urol 48:552–565
Plotti F, Zullo MA, Sansone M, Calcagno M, Bellati F, Angioli R et al (2009) Post radical hysterectomy urinary incontinence: a prospective study of transurethral bulking agents injection. Gynecol Oncol 112:90–94
McGuire EJ (2006) Urethral bulking agents. Nat Clin Pract Urol 3:234–235
Kotb AF, Campeau L, Corcos J (2009) Urethral bulking agents: techniques and outcomes. Curr Urol Rep 10:396–400
Lose G, Sorensen HC, Axelsen SM, Falconer C, Lobodasch K, Safwat T (2010) An open multicenter study of polyacrylamide hydrogel (Bulkamid(R)) for female stress and mixed urinary incontinence. Int Urogynecol J 21:1471–1477
ter Meulen PH, Berghmans LC, Nieman FH, van Kerrebroeck PE (2009) Effects of macroplastique implantation system for stress urinary incontinence and urethral hypermobility in women. Int Urogynecol J Pelvic Floor Dysfunct 20:177–183
Kelleher CJ, Cardozo LD, Khullar V, Salvatore S (1997) A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 104:1374–1379
Bjelic-Radisic V, Dorfer M, Tamussino K, Greimel E (2005) Psychometric properties and validation of the German-language King's Health Questionnaire in women with stress urinary incontinence. Neurourol Urodyn 24:63–68
Zhang XH, Xie F, Wee HL, Thumboo J, Li SC (2008) Applying the expectancy-value model to understand health values. Value Health 11(Suppl 1):S61–S68
Ryhammer AM, Djurhuus JC, Laurberg S (1999) Pad testing in incontinent women: a review. Int Urogynecol J Pelvic Floor Dysfunct 10:111–115
Lightner D, Rovner E, Corcos J, Payne C, Brubaker L, Drutz H et al (2009) Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopically. Urology 74:771–775
Kuhn A, Stadlmayr W, Sohail A, Monga A (2008) Long-term results and patients' satisfaction after transurethral ethylene vinyl alcohol (Tegress) injections: a two-centre study. Int Urogynecol J Pelvic Floor Dysfunct 19:503–507
Koski ME, Enemchukwu EA, Padmanabhan P, Kaufman MR, Scarpero HM, Dmochowski RR (2011) Safety and efficacy of sling for persistent stress urinary incontinence after bulking injection. Urology 77:1076–1080
Lee HN, Lee YS, Han JY, Jeong JY, Choo MS, Lee KS (2010) Transurethral injection of bulking agent for treatment of failed mid-urethral sling procedures. Int Urogynecol J 21:1479–1483
Pickard R, Reaper J, Wyness L, Cody DJ, McClinton S, N'Dow J (2003) Periurethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev CD003881
Klarskov N, Lose G (2008) Urethral injection therapy: what is the mechanism of action? Neurourol Urodyn 27:789–792
Gorton E, Stanton S, Monga A, Wiskind AK, Lentz GM, Bland DR (1999) Periurethral collagen injection: a long-term follow-up study. BJU Int 84:966–971
van KP, ter MF, Farrelly E, Larsson G, Edwall L, Fianu-Jonasson A (2003) Treatment of stress urinary incontinence: recent developments in the role of urethral injection. Urol Res 30:356–362
Kuhn A, Stadlmayr W, Lengsfeld D, Mueller MD (2008) Where should bulking agents for female urodynamic stress incontinence be injected? Int Urogynecol J Pelvic Floor Dysfunct 19:817–821
Sharifi-Aghdas F (2005) Surgical management of stress urinary incontinence. Urol J 2:175–182
Monga AK, Robinson D, Stanton SL (1995) Periurethral collagen injections for genuine stress incontinence: a 2-year follow-up. Br J Urol 76:156–160
Lightner D, Calvosa C, Andersen R, Klimberg I, Brito CG, Snyder J et al (2001) A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of Durasphere. Urology 58:12–15
Mayer RD, Dmochowski RR, Appell RA, Sand PK, Klimberg IW, Jacoby K et al (2007) Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence. Urology 69:876–880
Bano F, Barrington JW, Dyer R (2005) Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for urodynamic stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct 16:147–150
Ghoniem G, Corcos J, Comiter C, Bernhard P, Westney OL, Herschorn S (2009) Cross-linked polydimethylsiloxane injection for female stress urinary incontinence: results of a multicenter, randomized, controlled, single-blind study. J Urol 181:204–210
Ghoniem G, Corcos J, Comiter C, Westney OL, Herschorn S (2010) Durability of urethral bulking agent injection for female stress urinary incontinence: 2-year multicenter study results. J Urol 183:1444–1449
Mazouni C, Bladou F, Karsenty G, Giorgi R, Andre M, Serment G (2004) Minimally invasive surgery for female urinary incontinence: experience with periurethral microballoon implantation. J Endourol 18:901–905
Lose G, Mouritsen L, Nielsen JB (2006) A new bulking agent (polyacrylamide hydrogel) for treating stress urinary incontinence in women. BJU Int 98:100–104
Lottmann HB, Margaryan M, Lortat-Jacob S, Bernuy M, Lackgren G (2006) Long-term effects of dextranomer endoscopic injections for the treatment of urinary incontinence: an update of a prospective study of 61 patients. J Urol 176:1762–1766
Lottmann HB, Margaryan M, Bernuy M, Grosz A, Aigrain Y, Lortat-Jacob S et al (2006) Long-term effects of dextranomer endoscopic injections for treatment of urinary incontinence: an update of a prospective study of 31 patients. J Urol 175:1485–1489
Tsai CC, Lin V, Tang L (2006) Injectable biomaterials for incontinence and vesico-ureteral reflux: current status and future promise. J Biomed Mater Res B Appl Biomater 77:171–178
Palma PC, Riccetto CL, Martins MH, Herrmann V, de FR, Billis A et al (2006) Massive prolapse of the urethral mucosa following periurethral injection of calcium hydroxylapatite for stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 17:670–671
Kumar D, Kaufman MR, Dmochowski RR (2011) Case reports: periurethral bulking agents and presumed urethral diverticula. Int Urogynecol J 22:1039–1043
Madjar S, Sharma AK, Waltzer WC, Frischer Z, Secrest CL (2006) Periurethral mass formations following bulking agent injection for the treatment of urinary incontinence. J Urol 175:1408–1410
Sweat SD, Lightner DJ (1999) Complications of sterile abscess formation and pulmonary embolism following periurethral bulking agents. J Urol 161:93–96
Hartanto VH, Lightner DJ, Nitti VW (2003) Endoscopic evacuation of Durasphere. Urology 62:135–137
Kreder KJ, Austin JC (1996) Treatment of stress urinary incontinence in women with urethral hypermobility and intrinsic sphincter deficiency. J Urol 156:1995–1998
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mohr, S., Siegenthaler, M., Mueller, M.D. et al. Bulking agents: an analysis of 500 cases and review of the literature. Int Urogynecol J 24, 241–247 (2013). https://doi.org/10.1007/s00192-012-1834-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-012-1834-8